BEWATEC Technologies Co., Ltd.

BEWATEC was founded in Germany in 1995. After nearly 30 years of growth, its global businesses has stretched to more than 300,000 terminals in more than 1,200 hospitals in 15 countries.

BEWATEC has been focusing on smart medical care and is committed to the digital transformation of the global medical care industry, providing patients with comfortable, safe and personalized digital care journeys, thus becoming a global leader for specialized smart medical care overall solution (AIoT/ Internet Nursing).

The company has a market share of more than 60% in Germany and maintains cooperation with two-thirds of medical universities and institutions, including the world’s top ranking universities such as Freiburg University and Tübingen University. In China, BEWATEC has established ties with famous universities such as School of Medicine of the Fudan University, East China Normal University, etc. and the academician team of Jiaxing University, jointly working on scientific research, product development, and clinical trials.

Relying on the advantageous resources of talents, scientific research and market, BEWATEC manages to set up a post-doctoral workstation, which help accelerate the transformation of scientific and technological achievements by taking advantage of the global product layout, and promote the healthy, continuous, rapid and high-level development of industry.

BEWATEC has successively settled demonstrative outlets in Shanghai Ruijin Hospital, Shanghai Renji Hospital, Shanghai Changhai Hospital, Jiaxing Second Hospital and many other top-ranking hospitals in China, helping Ruijin Hainan Hospital to become a smart research hospital, where China’s first domestic Smart GCP ward and a national level smart palliative care center were created, contributing to the development of medical and health care industry.

As a global leader in seamless nursing services, we will be committed to our social responsibility of “pioneering and innovating, leading the revolution of products”, aiming at the deep entanglement of digitalization, IT and manufacturing so as to accelerate the combination of new technologies and clinical trials, to support high-quality care and efficient management, and making our contribution to the global Medicare industry.